Latest News & FeaturesMore News
All Events
Upcoming Events
  • Dr. Barry Arkles
    Gelest Inc.
    Elected 2021
    For contributions to organosilicon materials and organometallic and biochemical reagents.
    Full Bio More Members
  • Dr. Peter Fratzl
    Max Planck Institute of Colloids and Interfaces
    Elected 2021
    For studies of structure and physical properties of biological materials and their application in materials science and medicine.
    Full Bio More Members
  • Dr. Azad M. Madni
    Intelligent Systems Technology, Inc.
    Elected 2021
    For advances in low-cost simulation-based training using interdisciplinary model-based approaches.
    Full Bio More Members
  • Dr. Takuzo Aida
    University of Tokyo
    Elected 2021
    For contributions to the engineering of smart and adaptive molecular materials using physical perturbation of multivalent interactions.
    Full Bio More Members
  • Dr. Marinus A. Van den Brink
    Elected 2021
    For driving advances in optical and extreme ultraviolet lithography that enable smaller, faster, and more energy-efficient semiconductor devices.
    Full Bio More Members
President's Corner
NAE Perspectives
NAE Perspectives offer practitioners, scholars, and policy leaders a platform to comment on developments and issues relating to engineering.
  • image for Driverless Motor Vehicles: Not Yet Ready for Prime Time
    According to safety experts, more than 90% of motor vehicle crashes involve driver error,[1] and many believe that replacing drivers with automation could significantly reduce the number of crashes. Well-considered automation could compensate for human susceptibilities such as fatigue, distraction, and impairment that contribute to crashes, and thus greatly reduce the loss of nearly 40,000 lives every year on US streets and highways. Read more in a Perspective by Christopher A. Hart, founder of Hart Solutions LLC and former chair of the National Transportation Safety Board.
  • image for Protecting Human Health through Biotechnology Breakthroughs and Platforms
    Moderna spent a decade combining chemical, systems, and bio engineering advances to create the mRNA platform for its COVID-19 vaccine. On November 15, 2020, after 4 months in large-scale Phase 3 clinical testing, Moderna received resounding proof that its new class of medicines based on messenger RNA encased in lipid nanoparticles could be safely deployed as a highly effective vaccine to combat the covid-19 pandemic. Read the latest NAE Perspectives as chairman Noubar Afeyan explores lessons learned to stop other health threats.
  • image for ERs Rise to the Covid-19 Challenge: Teamwork between Engineers and Healthcare Providers Cuts ER Waiting Time
    Last year COVID-19 patients overwhelmed many hospital ERs.A process redesign implemented at one hospital, with 350 inpatient beds and 29 ER beds, illustrates how system engineering enabled us to better navigate the challenges of the global pandemic. A new NAE Perspective by HCA Healthcare, Brett Rungwerth and Kealoha Deutsch looks at how engineers teamed up with health care providers at HCA Healthcare to help speed patient care.
Stay in touch with NAE